CALIFORNIA | LOCAL
March 10, 2004 |
A 75-year-old man who was reported missing over the weekend was found Tuesday when a homeowner in East Long Beach heard moans in his backyard, police said. Kenneth Charles Heilman, who has Parkinson's disease, left his home for a doctor's appointment Friday and disappeared.
CALIFORNIA | LOCAL
March 9, 2004 |
Long Beach police are seeking the public's help in finding a 75-year-old man with Parkinson's disease who has been missing since Friday. Kenneth Charles Heilman left his home on Tevis Avenue for a 4 p.m. doctor's visit near Clark Avenue and Atherton Street. On Monday, police found his Saturn along the route to his doctor's office. Heilman is white, 5 feet 10, with a patch of gray hair and a mustache. He also has diabetes and needs medicine.
September 1, 2003 |
Researchers have suspected that inflammation is involved in Parkinson's disease, and now they've found that regular use of such inflammation-squelching drugs as ibuprofen, indomethacin, naproxen and diflunisa may reduce the risk. Two large groups participating in continuing studies -- the Health Professionals Follow-up Study and the Nurses' Health Study -- answered questionnaires about their health habits and histories every two years.
March 31, 2003 |
A preliminary trial on the safety of a drug for use by those with Parkinson's disease surprised scientists when all five patients in the test showed measurable improvement. The drug, GDNF, eliminated the periods of immobility that had occurred as much as 20% of the time before treatment and reduced or stopped the involuntary movements common to the disease, said Clive N. Svendsen of the University of Wisconsin Madison. The findings are in the online issue of Nature Medicine.
November 4, 2002 |
In pill form, antioxidants may not do much to prevent Parkinson's disease, new research indicates, but at least one shows promise when eaten in food. When researchers analyzed the food frequency questionnaires and supplement records of more than 100,000 participants in an ongoing health study, they discovered that getting large amounts of antioxidants from pills, even when combined with food sources, didn't help prevent Parkinson's disease.
June 16, 2002 |
In its end stages, Parkinson's disease can reduce its victims to a frozen, rigid, mute, unblinking, locked-in state. In writing about their struggles with this disease, Joel Havemann and Michael J. Fox display the opposite qualities: nimbleness, great passion, hyper-alertness and an awareness of what is meaningful in life--as if the disease has blessed them with special vision and a unique voice.
April 22, 2002 |
A new type of cell transplant to treat Parkinson's disease appears to significantly improve patients' movements while avoiding the ethical quandaries linked to fetal and stem cell use. The technique, which so far has been tested only in six patients, uses eye cells obtained from a cadaver donor.
CALIFORNIA | LOCAL
April 21, 2002 |
Several years ago, a USC Medical School professor showed her class a large depiction of Parkinson's disease. The series of drawings followed something like the evolution of man but in reverse, starting with an upright man and ending with a figure hunched over and shaking. Moses Remedios whispered to a fellow student, "Out of all the awful things we've learned about, this disease is the one I hope I never get." "Famous last words!"
September 27, 2001 |
Implanting minute electrodes in the brain is the most effective treatment for advanced Parkinson's disease and has fewer side effects than widely used surgeries that destroy brain tissue, an international team reports today. The technology, a kind of brain pacemaker, "can literally restore patients to independent function" when conventional drugs can no longer help them, said Dr. C.
August 13, 2001
Patients in clinical studies often feel relief even when they're given placebos--pills that don't contain medications. The cause, doctors think, is the power of the mind to influence the body. But the nature of the mind-body link is unclear. Now scientists at the University of British Columbia have an explanation for why such a strong "placebo effect" occurs in patients with the neurological condition known as Parkinson's disease.